← Back to Dashboard

DRREDDY Dr. Reddy's Laboratories Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 0.77%
₹ 1,180.00
-1.98%
1-year price · range ₹1,143–₹1,368

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Short Buildup
Short sellers are loading fresh positions (OI up +4.5%) on price weakness (-0.5%).

Analysis what the data is telling us about DRREDDY

In the last completed session, Dr. Reddy's Laboratories Ltd. closed -0.50% with futures open interest moving +4.5%. That combination — price falling while OI builds — is classified as Short Buildup. Fresh short positions are being added on weakness, which historically prefaces further downside until shorts are forced to cover. The stock's option PCR sits at 0.67, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,200 sits 1.7% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Dr. Reddy's Laboratories Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Dr. Reddy's Laboratories Ltd. points to a softer setup at the next open. The next scheduled earnings report is on 2026-10-23, with the consensus EPS estimate at ₹9.18554. Earnings days routinely override positioning signals — keep an eye on the calendar.

F&O Positioning EOD derivatives setup

Buildup Class
Short Buildup
bias: bearish
Futures OI
21,590,000
+923125 (+4.5%)
Option PCR (OI)
0.67
neutral option setup
Max Pain Strike
₹ 1,200
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,203.80
yesterday's EOD close
Index Contribution
-0.015 pp
contribution to Nifty
Traded Volume
2,278,637
live shares traded today
Upcoming Earnings
2026-10-23
EPS est: 9.18554

Technical Snapshot as of 2026-10-07 close · from 400 sessions of price history

RSI (14)
52.9
neutral momentum
52-Week High
₹ 1,414.90
-14.9% from high
52-Week Low
₹ 1,101.00
+9.3% above low
200-DMA
₹ 1,245.94
-3.4% · below trend
50-DMA
₹ 1,181.05
+1.9% from 50-DMA
1-Year Return
-3.6%
1M +4.6%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
29.7
price / earnings
P/B
2.6
price / book
ROE
8.8%
return on equity
Market Cap
₹ 98,293 Cr
total market value
Dividend Yield
0.68%
trailing yield
EPS (TTM)
₹ 39.74
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-10-27 · spot 1,204 · EOD 2026-10-07

Option writers expect range between 1,200 and 1,200 — -0.3% upside, -0.3% downside.
unbalanced
Call OI (writers) Strike Put OI (writers)
1,250
IV 46% Δ 0.73 θ -1.3 ν 1
1140
183,125 +44k
IV 30% Δ -0.19 θ -0.6 ν 1
13,750
IV 26% Δ 0.81 θ -0.7 ν 1
1150
222,500 +17k
IV 30% Δ -0.22 θ -0.6 ν 1
128,125 +1k
IV 18% Δ 0.84 θ -0.5 ν 1
1160
134,375 +20k
IV 30% Δ -0.27 θ -0.7 ν 1
22,500 +5k
IV 18% Δ 0.78 θ -0.6 ν 1
1170
90,625 +21k
IV 30% Δ -0.31 θ -0.7 ν 1
176,250 +20k
IV 21% Δ 0.69 θ -0.7 ν 1
1180
128,750 +42k
IV 30% Δ -0.36 θ -0.7 ν 1
217,500 +31k
IV 22% Δ 0.62 θ -0.7 ν 1
1190
158,750 +41k
IV 31% Δ -0.40 θ -0.8 ν 1
1,103,125 +51k
IV 23% Δ 0.56 θ -0.8 ν 1
1200 R S MP
1,056,875 +19k
IV 31% Δ -0.45 θ -0.8 ν 1
261,875 +83k
IV 23% Δ 0.50 θ -0.8 ν 1
1210
230,000 +27k
IV 31% Δ -0.50 θ -0.8 ν 1
786,875 +341k
IV 24% Δ 0.44 θ -0.8 ν 1
1220
379,375 +83k
IV 31% Δ -0.54 θ -0.8 ν 1
363,750 +176k
IV 24% Δ 0.38 θ -0.8 ν 1
1230
218,750 +32k
IV 32% Δ -0.58 θ -0.8 ν 1
509,375 +41k
IV 25% Δ 0.33 θ -0.7 ν 1
1240
230,000 +1k
IV 37% Δ -0.60 θ -0.9 ν 1
633,750 +75k
IV 25% Δ 0.28 θ -0.7 ν 1
1250
130,000 -5k
IV 32% Δ -0.67 θ -0.7 ν 1
478,125 +263k
IV 25% Δ 0.24 θ -0.6 ν 1
1260
58,125 +1k
IV 37% Δ -0.68 θ -0.8 ν 1

Chain Interpretation

Spot Underlying 1,203.79
Key Resistance (R) 1,200
Key Support (S) 1,200
Max Pain Strike (MP) 1,200
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for DRREDDY options · 2026-10-27 expiry

Underlying: DRREDDY · Spot: ₹ 1,203.79 · Expiry: 2026-10-27 · Lot: 625

Legs

Side
Type
Strike
Qty
Premium
Net premium—
Max profit—
Max loss—
Breakevens—
Position Delta—
Position Theta/day—
Position Vega/1% IV—

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

No recent news articles found for this stock.

DRREDDY — frequently asked questions

What is the Dr. Reddy's Laboratories Ltd. share price today?

DRREDDY is trading at ₹1,180.00 (-1.98% vs previous close), per the latest update on this page.

What is the P/E ratio of Dr. Reddy's Laboratories Ltd.?

DRREDDY (Dr. Reddy's Laboratories Ltd.) has a trailing twelve-month P/E ratio of 29.7.

What is the market cap of Dr. Reddy's Laboratories Ltd.?

DRREDDY has a market capitalisation of approximately ₹98,293 crore.

What is the ROE of Dr. Reddy's Laboratories Ltd.?

DRREDDY has a return on equity (ROE) of about 8.8%.

Is DRREDDY near its 52-week high?

DRREDDY is trading -14.9% from its 52-week high of ₹1,414.90 as of 2026-10-07.

What is the RSI of DRREDDY?

The 14-day RSI of DRREDDY is 52.9, which is considered neutral.

Is DRREDDY above its 200-day moving average?

DRREDDY is trading below its 200-DMA of ₹1,245.94 (-3.4% away).

What is the F&O buildup in DRREDDY?

The latest end-of-day derivatives data classifies DRREDDY as Short Buildup (bias: bearish), based on the day's combined price and open-interest change.

What is the max pain and PCR for DRREDDY options?

DRREDDY's option-chain max pain strike is ₹1,200 and its put-call ratio (OI) is 0.67, from the latest end-of-day option chain.

Are FIIs or big investors buying DRREDDY?

Strota tracks every bulk and block deal in DRREDDY with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.